New Orleans, LA - Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the LSU Health New Orleans Neuroscience Center of Excellence, discovered a protein in the retina that is crucial for vision. The paper reports, for the first time, the key molecular mechanisms leading to visual degeneration and blindness. The research reveals events that may be harnessed for prevention, as well as to slow down progression of retinal degenerative diseases. The paper is published in the March 4, 2015, issue of Nature Communications.
There is growing evidence of the significance of the essential omega-3 fatty acid family member, docosahexaenoic acid (DHA), for photoreceptor function and in retinal degenerative diseases, but not much understanding about what governs it. The research team found that the protein receptor for adiponectin, a hormone that promotes insulin sensitivity and is involved in the metabolic syndrome, has a heretofore unrecognized function. The receptor also regulates DHA retention and conservation in cells in the eye and is necessary for photoreceptor cell function.
"This is the first time that such an integral membrane protein has been localized in the photoreceptor cells and shown to have the capacity to support sight," notes Dr. Bazan, the paper's corresponding author.
Working with a novel genetic mouse model they developed with the adiponectin receptor gene deleted, the researchers found that total and free retinal DHA were diminished in the gene-deficient mice. When they incubated normal retinas with labeled DHA, they measured abundant levels of it, demonstrating that a functional AdipoR1 gene must be present for DHA uptake and retention. Additionally, when cultured human Retinal Pigment Epithelial (RPE) cells were incubated with labeled DHA, DHA within the medium decreased with time while increasing within the cells. Also, when the AdipoR1 gene activity was ramped up in these cultured RPE cells, much more labeled DHA was taken up and incorporated. But when silenced, labeled DHA was diminished, indicating that human RPE cells can also take up DHA and that the AdipoR1 gene plays a significant role in this activity, too.
DHA in brain and retinal cells also builds reservoirs for molecules called into action when normal functions are disrupted, resulting in such conditions as retinal degeneration, Parkinson's or Alzheimer's disease. Dr. Bazan and his colleagues previously discovered neuroprotectin D1 (NPD1), one such molecule made from DHA when cell survival is compromised. Loss of, or diminished, retinal DHA leads to visual impairment and may play an important role in the development of blindness from retinitis pigmentosa and other retinal degenerative diseases, as well as age-related macular degeneration (AMD), the foremost cause of blindness in people older than 50 years.
"Our model and newly discovered molecular mechanism allow therapies to be tested more rapidly," notes Dr. Bazan. "We feel an urgency to address blindness and cognition impairments of dementias because of their heavy burden on patients, families, care givers and the health care system."
DHA, found in fish oil, is an essential omega-3 fatty acid and is vital for proper brain function. It is also necessary for the development of the nervous system, including vision. Dr. Bazan has been a pioneer in the understanding of the biology and impact of DHA in medicine.
###
Other members of the LSU Health New Orleans research team include Drs. William Gordon, Minghao Jin, Jorgelina Calandria, Bok Kyoo Jun, Yondong Zhou, Songhua Li and Eric Knott. As well, this paper reflects an academic collaboration between Dr. Bazan and Dr Dennis Rice and colleagues from Lexicon Pharmaceuticals in Houston, Texas.
This work was supported by National Institutes of Health (NIH) grants R01 EY005121 (National Eye Institute) and P30 GM103340 (National Institute of General Medical Sciences), the Eye Ear Nose and Throat Foundation of New Orleans and in part by the Research to Prevent Blindness, New York, NY.
Dr. Bazan and colleagues are named inventors of patents filed on this new molecule essential for vision. LSU Health New Orleans is the assignee of the patents.
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's health university leader, LSUHSC includes a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. LSUHSC faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu, http://www.twitter.com/LSUHealthNO or http://www.facebook.com/LSUHSC.
Journal
Nature Communications